succinylacetone has been researched along with nitisinone in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 11 (68.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Hjalmarson, O; Holme, E; Lindstedt, S; Lock, EA; Strandvik, B | 1 |
| al-Dhalimy, M; Finegold, M; Grompe, M; Kennaway, NG; Lindstedt, S; Ou, CN; Papaconstantinou, J; Torres-Ramos, CA | 1 |
| Barkaoui, E; Bernard, O; Debray, D; Habès, D; Ogier, H | 1 |
| Al Amoudi, M; Al-Ahaidib, LY; Al-Dbaas, A; Al-Dirbashi, OY; Al-Hassnan, Z; Al-Owain, M; Al-Sayed, MM; Ni Luanaigh, M; Rahbeeni, Z; Rashed, MS | 1 |
| Al-Dirbashi, O; El-Hawary, M; El-Karaksy, H; El-Koofy, N; El-Raziky, M; El-Sayed, R; Rashed, M | 1 |
| Boenzi, S; Della Bona, ML; Dionisi-Vici, C; la Marca, G; Malvagia, S; Martinelli, D; Materazzi, S | 1 |
| Herebian, D; Schlune, A; Spiekerkoetter, U; Thimm, E | 1 |
| Bartlett, DC; Holme, E; Lloyd, C; McKiernan, PJ; Newsome, PN; Preece, MA | 1 |
| Benoist, JF; Davit-Spraul, A; Garcia Segarra, N; Grenèche, MO; Imbard, A; Ogier de Baulny, H; Roche, S | 1 |
| Al Jurayyan, NA; Al-Jarallah, AS; Al-Nemri, A; Babiker, A; Hasanato, R; Kambal, MA; Mohamed, S | 1 |
| Peake, RW | 1 |
| Mannion, MA; Mayne, P; Monavari, AA; Smith, A | 1 |
| Alvarez, F; Atkinson, S; Bouchard, M; Brunel-Guitton, C; Buhas, D; Bussières, JF; Dubois, J; Fenyves, D; Goodyer, P; Gosselin, M; Halac, U; Labbé, P; Laframboise, R; Maranda, B; Melançon, S; Merouani, A; Mitchell, GA; Mitchell, J; Parizeault, G; Pelletier, L; Phan, V; Turcotte, JF | 1 |
| Christensen, M; Lund, AM; Sundberg, J; Wibrand, F | 1 |
| Burgerhof, JGM; Daly, A; de Blaauw, P; Heiner-Fokkema, MR; Kienstra, NS; MacDonald, A; Rodenburg, IL; Santra, S; van de Krogt, J; van Ginkel, WG; van Reemst, HE; van Spronsen, FJ | 1 |
| Gavrilov, DK; Matern, D; Netzel, BC; Oglesbee, D; Pino, GB; Raymond, KM; Rinaldo, P; Schultz, MJ; Singh, RH; Smith, WE; Tortorelli, S | 1 |
1 review(s) available for succinylacetone and nitisinone
| Article | Year |
|---|---|
The Québec NTBC Study.
Topics: Cyclohexanones; Enzyme Inhibitors; Heptanoates; Humans; Infant, Newborn; Liver Diseases; Liver Transplantation; Neonatal Screening; Nitrobenzoates; Quebec; Tyrosinemias | 2017 |
15 other study(ies) available for succinylacetone and nitisinone
| Article | Year |
|---|---|
Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.
Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Acetoacetates; alpha-Fetoproteins; Amino Acid Metabolism, Inborn Errors; Aminolevulinic Acid; Child; Child, Preschool; Cyclohexanones; Erythrocytes; Heptanoates; Humans; Hydroxybenzoates; Infant; Kidney Tubules; Liver; Nitrobenzoates; Phenylalanine; Phosphates; Porphobilinogen Synthase; Proteinuria; Tyrosine | 1992 |
Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I.
Topics: alpha-Fetoproteins; Amino Acid Metabolism, Inborn Errors; Amino Acids; Animals; Cyclohexanones; Disease Models, Animal; Enzyme Inhibitors; Female; Heptanoates; Humans; Hydrolases; Liver; Liver Diseases; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Nitrobenzoates; Pancreas; RNA, Messenger; Tyrosine | 1995 |
[Favorable outcome of treatment with NTBC of acute liver insufficiency disclosing hereditary tyrosinemia type I].
Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Acute Disease; Amino Acid Metabolism, Inborn Errors; Aminolevulinic Acid; Cyclohexanones; Enzyme Inhibitors; Female; Follow-Up Studies; Heptanoates; Humans; Infant; Infant, Newborn; Liver Failure; Male; Methionine; Nitrobenzoates; Porphobilinogen Synthase; Treatment Outcome; Tyrosine | 1999 |
Tandem mass spectrometric assay of succinylacetone in urine for the diagnosis of hepatorenal tyrosinemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclohexanones; Enzyme Inhibitors; Heptanoates; Humans; Infant; Infant, Newborn; Mass Spectrometry; Middle Aged; Neonatal Screening; Nitrobenzoates; Reproducibility of Results; Tyrosinemias | 2005 |
Clinical practice. NTBC therapy for tyrosinemia type 1: how much is enough?
Topics: Child, Preschool; Cost-Benefit Analysis; Cyclohexanones; Dose-Response Relationship, Drug; Drug Costs; Egypt; Enzyme Inhibitors; Female; Heptanoates; Humans; Infant; Nitrobenzoates; Tyrosinemias | 2010 |
LC-MS/MS method for simultaneous determination on a dried blood spot of multiple analytes relevant for treatment monitoring in patients with tyrosinemia type I.
Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Adolescent; Biomarkers; Child; Child, Preschool; Chromatography, Liquid; Cyclohexanones; Diet, Protein-Restricted; Drug Monitoring; Enzyme Inhibitors; Heptanoates; Humans; Infant; Infant, Newborn; Kidney; Liver; Methionine; Nitrobenzoates; Phenylalanine; Tandem Mass Spectrometry; Tyrosine; Tyrosinemias | 2012 |
Single dose NTBC-treatment of hereditary tyrosinemia type I.
Topics: Cyclohexanones; Drug Administration Schedule; Female; Heptanoates; Humans; Infant; Infant, Newborn; Male; Nitrobenzoates; Tyrosinemias | 2012 |
Plasma succinylacetone is persistently raised after liver transplantation in tyrosinaemia type 1.
Topics: Adolescent; Child; Child, Preschool; Cyclohexanones; Heptanoates; Humans; Infant; Liver Transplantation; Nitrobenzoates; Porphobilinogen Synthase; Retrospective Studies; Tyrosinemias | 2013 |
Maternal and fetal tyrosinemia type I.
Topics: Biomarkers; Child Development; Consanguinity; Cyclohexanones; Diet, Protein-Restricted; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; Heptanoates; Heredity; Heterozygote; Homozygote; Humans; Hydrolases; Infant; Infant, Newborn; Live Birth; Mutation; Nitrobenzoates; Pedigree; Phenotype; Pregnancy; Tyrosine; Tyrosinemias; Young Adult | 2010 |
Tyrosinemia type 1: a rare and forgotten cause of reversible hypertrophic cardiomyopathy in infancy.
Topics: Cardiomyopathy, Hypertrophic; Cyclohexanones; Food, Formulated; Heptanoates; Homozygote; Humans; Hydrolases; Infant; Male; Mutation; Nitrobenzoates; Siblings; Treatment Outcome; Tyrosinemias | 2013 |
Deranged Liver Function in a Neonate.
Topics: Biomarkers; Cyclohexanones; Enzyme Inhibitors; Female; Gas Chromatography-Mass Spectrometry; Heptanoates; Humans; Infant, Newborn; Liver Diseases; Neonatal Screening; Nitrobenzoates; Tyrosinemias; Urinalysis | 2016 |
Type 1 Tyrosinaemia.
Topics: Biomarkers; Cyclohexanones; Enzyme Inhibitors; Heptanoates; Humans; Hydrolases; Hypoglycemia; Ireland; Liver Transplantation; Mutation; Nitrobenzoates; Tyrosinemias | 2016 |
Simultaneous quantification of succinylacetone and nitisinone for therapeutic drug monitoring in the treatment of Tyrosinemia type 1.
Topics: Chromatography, Liquid; Cyclohexanones; Drug Monitoring; Heptanoates; Humans; Linear Models; Nitrobenzoates; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Tyrosinemias | 2018 |
The Effect of Various Doses of Phenylalanine Supplementation on Blood Phenylalanine and Tyrosine Concentrations in Tyrosinemia Type 1 Patients.
Topics: Adolescent; Adult; Child; Cyclohexanones; Dietary Supplements; Enzyme Inhibitors; Female; Heptanoates; Humans; Linear Models; Male; Nitrobenzoates; Phenylalanine; Tyrosine; Tyrosinemias; Young Adult | 2019 |
Laboratory monitoring of patients with hereditary tyrosinemia type I.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acids; Biomarkers; Case-Control Studies; Child; Child, Preschool; Cyclohexanones; Female; Follow-Up Studies; Heptanoates; Humans; Infant; Infant, Newborn; Laboratories; Male; Middle Aged; Nitrobenzoates; Prognosis; Reference Standards; Specimen Handling; Tyrosinemias; Young Adult | 2020 |